` GRANULES (Granules India Ltd) vs BSE Sensex 30 Comparison - Alpha Spread

GRANULES
vs
B
BSE Sensex 30

Over the past 12 months, GRANULES has significantly outperformed BSE Sensex 30, delivering a return of +37% compared to the BSE Sensex 30's 1% drop.

Stocks Performance
GRANULES vs BSE Sensex 30

Loading
GRANULES
BSE Sensex 30
Add Stock
www.alphaspread.com
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
GRANULES vs BSE Sensex 30

Loading
GRANULES
BSE Sensex 30
Difference
www.alphaspread.com

Performance By Year
GRANULES vs BSE Sensex 30

Loading
GRANULES
BSE Sensex 30
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Competitors Performance
Granules India Ltd vs Peers

BSE Sensex 30
GRANULES
JEF
JNJ
4312
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Granules India Ltd
Glance View

In the bustling corridors of the pharmaceutical world, Granules India Ltd. has carved out a distinctive niche through its unwavering commitment to efficiencies and economies of scale. Founded in 1984, the company began its journey as an operator of a small Paracetamol facility and steadily evolved into a formidable player on the global stage. Granules India's business model is streamlined; it meticulously integrates its manufacturing processes, focusing primarily on Active Pharmaceutical Ingredients (APIs), Pharmaceutical Formulation Intermediates (PFIs), and Finished Dosage Forms (FDFs). By leveraging vertically integrated operations, the company ensures a seamless transition from raw material to finished product, reducing costs while maintaining high standards of product quality, an achievement that distinguishes it in the competitive landscape. Granules India capitalizes on its robust manufacturing infrastructure, which operates round the clock to serve a diverse clientele spanning across regulated and semi-regulated markets. This emphasis on cost-effective production is coupled with strategic geographical placement of its facilities, allowing it to cater efficiently to domestic and international markets, including North America, Europe, and emerging economies. The company's revenue streams are largely driven by the sales of its extensive product portfolio, which includes key therapeutic areas like over-the-counter (OTC) brands and prescription medications. By maintaining a diversified product line and emphasizing high-volume, low-margin products, Granules India continually fortifies its market position while sustaining a healthy balance between growth and stability.

GRANULES Intrinsic Value
564.33 INR
Overvaluation 14%
Intrinsic Value
Price ₹656.5
Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett